Skip to content

surmount-1 tirzepatide trial weight loss non-diabetic SURMOUNT-1 (NEJM 2022) tested tirzepatide — a dual GIP/GLP-1 receptor agonist — in 2,539 adults with obesity and achieved up to 20.9% mean weight loss at the highest dose. 57% of participants

Marsoni M251S
Sale price$27.81
Pay 4 payments of $6.95 a month.Shop Pay
Get it in 3 business days with 1 day shipping. Friday, May 29
The Weight Loss Breakthrough: Tirzepatide in Delray Beach VidaVital MD Eli Lilly Trial Shows Superior Outcomes With Ixekizumab and Tirzepatide in Patients With PsA and Obesity Dermatology Times Tirzepatide Side Effects and How to Overcome Them Heally In the SURMOUNT 5 phase 3b trial involving adults with obesity without type 2 diabetes, tirzepatide was superior to semaglutide in reducing body weight and waist circumference. Full trial results and Research Summary: Semaglutide vs Tirzepatide: Which Option Is Right for You?
Easy Shipping

Quick Dispatch:

Your surmount-1 tirzepatide trial weight loss non-diabetic SURMOUNT-1 (NEJM 2022) tested tirzepatide — a dual GIP/GLP-1 receptor agonist — in 2,539 adults with obesity and achieved up to 20.9% mean weight loss at the highest dose. 57% of participants orders ship within 1-2 business days.

Delivery Options:

  • Standard: 3-7 business days
  • Fast: 2-3 business days
  • Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your surmount-1 tirzepatide trial weight loss non-diabetic SURMOUNT-1 (NEJM 2022) tested tirzepatide — a dual GIP/GLP-1 receptor agonist — in 2,539 adults with obesity and achieved up to 20.9% mean weight loss at the highest dose. 57% of participants ships.

Need Help?
Questions about surmount-1 tirzepatide trial weight loss non-diabetic SURMOUNT-1 (NEJM 2022) tested tirzepatide — a dual GIP/GLP-1 receptor agonist — in 2,539 adults with obesity and achieved up to 20.9% mean weight loss at the highest dose. 57% of participants, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for surmount-1 tirzepatide trial weight loss non-diabetic SURMOUNT-1 (NEJM 2022) tested tirzepatide — a dual GIP/GLP-1 receptor agonist — in 2,539 adults with obesity and achieved up to 20.9% mean weight loss at the highest dose. 57% of participants in your area.

Get Shipping Estimates

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy
4.8 ★★★★★
Based on 57 reviews
Sort
Highest Rating
Newest First
Oldest First
Product Reviews
S
Verified Purchase
Sue
Omaha, US
★★★★★ 5
Soap
Makes skin so soft
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 1, 2026
L
Verified Purchase
Lizz
Birmingham, US
★★★★★ 5
Great lather
I bought this for my husband and he loves it so much, I will have to try it myself! He says there is no scent at all and it lathers very well.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 9, 2026
J
Verified Purchase
jennifer hogan
Birmingham, US
★★★★★ 5
Good quality
Good price compared to other brands. Also lasted longer than the other I have tried.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on November 18, 2025
S
Verified Purchase
StarshaS
Alexandria, US
★★★★★ 5
Will order again!
This soap worked wonders for my psoriasis. It was very gentle on my skin. The bars lasted a long time which I feel like made it worth the money. The ingredients being all natural is also a plus for this product. While it didn't make my psoriasis flaw-up go away it did help with the itchiness of the areas. And it just soothe my skin.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 7, 2026
S
Verified Purchase
Sue
New York, US
★★★★★ 5
Great product.
I bought this as a Christmas gift for my son who has eczema. He told me that he uses it daily and have had no issues and been eczema free since.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 18, 2026

recommand products